{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:33Z","timestamp":1781626053482,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chief Scientist Office of the Ministry of Health, Israel","award":["grant no. 3-18678 From"],"award-info":[{"award-number":["grant no. 3-18678 From"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although recreational cannabis is not yet legalized in Israel, the increase in cannabis prescriptions may lead to an increase in its availability and abuse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate temporal changes in the prevalence of cannabis-positive urine toxicology tests among individuals admitted to the emergency department (ED) in a large tertiary medical center in Israel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Between January\/2016 and June\/2024, all ED-admitted individuals who had urine toxicology tests (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920,022) were included.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Screening with urine toxicology increased from 0.7% in 2016 to 1.3% in 2024 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Of all screened patients, 16.8% (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20093361) were cannabis-positive, rising from 15.4% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009112) in January-June\/2016 to 17.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009246) in January-June\/2024 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with an increasing trend (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) among the aged 25-64y group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911901) from 16.6% in January-June\/2016 to 22.4% in January-June\/2024, and the highest proportion in &lt;\u200925y age group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092935, 23.8%). Logistic regression showed that later years (OR\u2009=\u20091.03, 95%CI 1.01\u20131.05), male sex (OR\u2009=\u20091.5, 95%CI 1.4\u20131.6), younger age (compared with aged\u2009\u2265\u200965, aged\u2009&lt;\u200925, (OR\u2009=\u20094.1, 95%CI 3. 5-4.8), aged 25\u201364 (OR\u2009=\u20093.3, 95% CI 2.9\u20133.8)), Israeli-born (OR\u2009=\u20091.3, 95% CI 1.2\u20131.4), screening positive for opioid(OR\u2009=\u20091.4, 95%CI 1.2\u20131.5), MDMA (OR\u2009=\u20091.8, 95%CI 1.5\u20132.2), cocaine (OR\u2009=\u20091.3, 95%CI 1.2\u20131.5) methamphetamine (OR\u2009=\u20091.4, 95%CI 1.1\u20131.7) and not being hospitalized (OR\u2009=\u20091.4, 95%CI 1.3\u20131.5).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The exponential increase in cannabis prescriptions was not reflected in the modest increase in the proportion of cannabis-positive urine toxicology samples, that characterized the 25\u201364 age group. However, results may be biased, as toxicology screens were based on clinical suspicion without standardized ordering criteria, and diagnostic information regarding the ED visit was absent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00379-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:05:59Z","timestamp":1766513159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in urine screening positive for cannabis of emergency department admissions in Israel 2016\u20132024"],"prefix":"10.1186","volume":"8","author":[{"given":"Oren","family":"Miron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zeltser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-0693","authenticated-orcid":false,"given":"Shaul","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Adelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7091-7987","authenticated-orcid":false,"given":"Einat","family":"Peles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"379_CR1","doi-asserted-by":"publisher","first-page":"1060656","DOI":"10.3389\/fpsyt.2022.1060656","volume":"13","author":"M Athanassiou","year":"2023","unstructured":"Athanassiou M, Dumais A, Zouaoui I, Potvin S. The clouded debate: a systematic review of comparative longitudinal studies examining the impact of recreational cannabis legalization on key public health outcomes. Front Psychiatry. 2023;13:1060656.","journal-title":"Front Psychiatry"},{"key":"379_CR2","unstructured":"Bar-Hamburger R, Ezrahi Y, Rosiner I, Nirel R. Illegal use of drugs and alcohol in Israel 2009, seventh national epidemiological survey. Jerusalem. 2009."},{"key":"379_CR6","doi-asserted-by":"crossref","unstructured":"Chan O, Daudi A, Ji D, Wang M, Steen JP, Parnian P, et al. Cannabis use during adolescence and young adulthood and academic achievement: a systematic review and meta-analysis. JAMA Pediatr. 2024;178:1280\u20139.e243674.","DOI":"10.1001\/jamapediatrics.2024.3674"},{"key":"379_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108842","volume":"225","author":"NG Choi","year":"2021","unstructured":"Choi NG, Choi BY, Marti CN, DiNitto DM. Is cannabis use associated with prescription psychotropic and pain reliever medication and other substance use among individuals aged 50\u2009+\u2009with mental illness? Drug Alcohol Depend. 2021;225:108842.","journal-title":"Drug Alcohol Depend"},{"key":"379_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.008","author":"WM Compton","year":"2019","unstructured":"Compton WM, Han B, Jones CM, Blanco C. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug Alcohol Depend. 2019;204:107468. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.008.","journal-title":"Drug Alcohol Depend"},{"key":"379_CR9","doi-asserted-by":"publisher","first-page":"1093081","DOI":"10.3389\/fpsyt.2023.1093081","volume":"14","author":"CE Crocker","year":"2023","unstructured":"Crocker CE, Emsley J, Tibbo PG. Mental health adverse events with cannabis use diagnosed in the emergency department: what are we finding now and are our findings accurate? Front Psychiatry. 2023;14:1093081.","journal-title":"Front Psychiatry"},{"key":"379_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13011-023-00562-x","volume":"18","author":"Y Cui","year":"2023","unstructured":"Cui Y, LoParco CR, Bar-Zeev Y, Duan Z, Levine H, Abroms LC, et al. Theory-based correlates of cannabis use and intentions among US and Israeli adults: a mixed methods study. Subst Abuse Treat Prev Policy. 2023;18:54.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"379_CR11","first-page":"5778","volume":"1","author":"Dangerous Drugs Law","year":"2019","unstructured":"Dangerous Drugs Law. (Special fine Offence \u2013 Temporary order. State Isr Effective April. 2019;1:5778\u20132018.","journal-title":"State Isr Effective April"},{"key":"379_CR12","first-page":"603","volume":"6","author":"MA ElSohly","year":"2021","unstructured":"ElSohly MA, Chandra S, Radwan M, Majumdar CG, Church JC. A comprehensive review of cannabis potency in the united States in the last decade. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:603\u20136.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"379_CR13","volume-title":"Psychoactive drug use among the adult population in Israel- National epidemiological survey","author":"Y Ezrachi","year":"2017","unstructured":"Ezrachi Y, Dayan Y, Rosiner I, Harel-Fisch Y. Psychoactive drug use among the adult population in Israel- National epidemiological survey. Jerusalem: Israel Anti-Drug Authority; 2017. (In Hebrew)."},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/dar.13031","volume":"39","author":"D Feingold","year":"2020","unstructured":"Feingold D, Livne O, Rehm J, Lev-Ran S. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: results from a large-scale nationally representative study. Drug Alcohol Rev. 2020;39:142\u201351.","journal-title":"Drug Alcohol Rev"},{"key":"379_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102698","volume":"77","author":"D Hammond","year":"2020","unstructured":"Hammond D, Goodman S, Wadsworth E, Rynard V, Boudreau C, Hall W. Evaluating the impacts of cannabis legalization: the International Cannabis Policy Study. Int J Drug Policy. 2020;77:102698.","journal-title":"Int J Drug Policy"},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/acem.14275","volume":"28","author":"RG Hendrickson","year":"2021","unstructured":"Hendrickson RG, Dilley JA, Hedberg K, Jeanne TL, Love JS, Thompson JA, et al. The burden of cannabis-attributed pediatric and adult Emergency Department visits. Acad Emerg Med. 2021;28:1444\u20137.","journal-title":"Acad Emerg Med"},{"key":"379_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2021.102709","volume":"58","author":"R Isralowitz","year":"2021","unstructured":"Isralowitz R, Reznik A, Zolotov Y, Grinstein-Cohen O, Wacht O, Pruginin I, et al. Toward medical cannabis education in Israel. Complement Ther Med. 2021;58:102709.","journal-title":"Complement Ther Med"},{"key":"379_CR19","doi-asserted-by":"publisher","first-page":"112680","DOI":"10.1016\/j.drugalcdep.2025.112680","volume":"272","author":"AF Kritikos","year":"2025","unstructured":"Kritikos AF, Taylor B, Lamuda P, Pollack H, Schneider JA. Patterns of past month cannabis consumption and cannabis use disorder - Insights from a nationally representative survey. Drug Alcohol Depend. 2025;272:112680.","journal-title":"Drug Alcohol Depend"},{"key":"379_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/15563650.2011.609822","volume":"49","author":"J Lapoint","year":"2011","unstructured":"Lapoint J, James L, Moran C, Nelson L, Hoffman R, Moran J. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011;49:760\u20134.","journal-title":"Clin Toxicol (Phila)"},{"key":"379_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106479","volume":"109","author":"J Leung","year":"2020","unstructured":"Leung J, Chan GC, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav. 2020;109:106479.","journal-title":"Addict Behav"},{"key":"379_CR23","unstructured":"Library of Congress, Law Library. Decriminalization of Narcotics: Israel. 2019. https:\/\/www.loc.gov\/law\/help\/decriminalization-of-narcotics\/israel.php"},{"key":"379_CR24","unstructured":"MOH (Ministry of Health). https:\/\/www.gov.il\/BlobFolder\/reports\/licenses-status-june-2025\/he\/subjects_cannabis_docs_licenses-status-june-2025.pdf"},{"key":"379_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/adb.12606","volume":"24","author":"S Schreiber","year":"2019","unstructured":"Schreiber S, Bader M, Lenchinski T, Meningher I, Rubovitch V, Katz Y, Cohen E, Gabet Y, Rotenberg M, Wolf E, Pick CG. Functional effects of synthetic cannabinoids vs. \u22069-THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor\/exploratory parameters, and depression. Addict Biol. 2019;24:414\u201325.","journal-title":"Addict Biol"},{"key":"379_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/15563650.2019.1657582","volume":"58","author":"SK Shelton","year":"2020","unstructured":"Shelton SK, Mills E, Saben JL, Devivo M, Williamson K, Abbott D, Hall KE, Monte AA. Why do patients come to the emergency department after using cannabis? Clin Toxicol (Phila). 2020;58:453\u20139.","journal-title":"Clin Toxicol (Phila)"},{"key":"379_CR27","unstructured":"UNODC. World drug report 2023. United Nations Office on Drugs and Crime, New York, NY."},{"key":"379_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001216","volume":"9","author":"NT Vozoris","year":"2022","unstructured":"Vozoris NT, Zhu J, Ryan CM, Chow C-W, To T. Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study. BMJ Open Respir Res. 2022;9:e001216.","journal-title":"BMJ Open Respir Res"},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1017\/cem.2020.384","volume":"22","author":"MEM Yeung","year":"2020","unstructured":"Yeung MEM, Weaver CG, Janz K, Haines-Saah R, Lang E. Clearing the air: a study of cannabis-related presentations to urban Alberta emergency departments following legalization. CJEM. 2020;22:776\u201383.","journal-title":"CJEM"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00379-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:40:39Z","timestamp":1781624439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-025-00379-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00379-4","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Helsinki Committee (IRB) standard of Tel Aviv Sourasky Medical Center (TASMC) is in accordance with the Declaration of Helsinki. The TASMC Helsinki Committee approved the study analyses (approval number TASMC-0503-22). Human Ethics and Consent to Participate declarations are not applicable, as only de-identified retrospective data were included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}